Achilles Corporation · TSE:5142

Achilles — FY2025 Earnings Presentation

33 slides from Achilles's earnings presentation, Jun 8, 2026

  1. Slide 1: Financial Results Briefing for the Fiscal Year Ended March 31, 2026

    Achilles Corporation Securities code: 5142, Tokyo Stock Exchange Prime Market Financial Results Briefing for the Fiscal Year Ended March 31, 2026 June 8, 2026 Copyright© ACHILLES CORPORATION All Rights Reserved.

  2. Slide 2: Key Points

    Key Points 1. A combination of structural reforms and our growth strategy enabled us to significantly improve performance ⚫ We used the restructuring of our business organizations as an opportunity to thoroughly select and concentrate our businesses. ⚫ Our performance was driven by a growing busines

  3. Slide 3: Agenda

    Section 1: Business Summary and Initiatives to Improve Profitability P. 3 Section 2: Overview of Financial Results for the Fiscal Year Ended March 31, 2026 P. 14 Agenda Section 3: Financial Forecasts for the Fiscal Year Ending March 31, 2027 P. 22 Section 4: Financial and Capital Strategy P. 28 2 Co

  4. Slide 4: Business Summary and Initiatives to Improve Profitability

    Business Summary and Initiatives to Section 1 Improve Profitability 3 Copyright© ACHILLES CORPORATION All Rights Reserved.

  5. Slide 5: Company Profile

    1. Company Profile Company name: Achilles Corporation Listed exchange (securities code): TSE Prime Market (5142) Established: May 1947 Capital: 14,600,000,000 yen Representative: Ichiro Hikage, Representative Director and President Head office: Shinjuku Front Tower, 2-21-1 Kitashinjuku, Shinjuku-ku,

  6. Slide 6: Our Core Technologies

    2. Our Core Technologies Creating 「膜」 a diverse array 多種多様な、 of films をつくる。 We operate a wide variety of businesses founded on plastic processing technologies. Film-forming technologies We possess a wide array of elemental technologies based on our three core film- From the production of films and s

  7. Slide 7: Our Business Domains and Major Products

    3. Our Business Domains and Major Products Our products support the everyday lives of consumers and a wide array of industries. They also provide value in life-saving settings. Maintenance and repair work (aging management) Manufacturing Partitioning film curtains Interiors and Housing interior mate

  8. Slide 8: Net Sales by Business Segment

    4. Net Sales by Business Segment Results for the fiscal year Reference: We began working in new segments ended March 31, 2026 in the fiscal year ended March 31, 2026. Consolidated net sales: 81.8 billion yen New BU Major products segments Automotive interior materials and furniture Automotive Materi

  9. Slide 9: Overview of the Medium-Term Management Plan (FY2025 to FY2027)

    5. Overview of the Medium-Term Management Plan (FY2025 to FY2027) Up to FY2030 (Expansion Phase) FY2025 to FY2027 (Rebuilding and Enhancement Phase) - Honing technologies and solutions through R&D for priority sectors and Up to FY2024 (Recovery Phase) - Improving profitability by implementing three

  10. Slide 10: Position of the Medium-Term Management Plan

    6. Position of the Medium-Term Management Plan Our FY2030 Goal (Vision 2030) At the Achilles Group, we value the curiosity of each one of our employees, their diverse abilities, unique ideas, and inspirations, and we contribute to society leveraging solutions created by combining various technologie

  11. Slide 11: Company-wide Strategy (1): Thorough Selection and Concentration of Businesses

    7. Company-wide Strategy (1): Thorough Selection and Concentration of Businesses ◆ We will continue to move forward with priority selection and concentration measures within the shoes business and the automotive materials business, which require structural reform. Medium-Term Management Plan (Republ

  12. Slide 12: Company-wide Strategy (2): Creation of New Value

    8. Company-wide Strategy (2): Creation of New Value ◆ We restructured our business organizations in June 2025 to create new value by combining technologies based on creative ideas. ◆ To create more synergy, we will implement cross-functional collaborations to approach priority sectors. 1 Building a

  13. Slide 13: Company-wide Strategy (3): Promotion of Our Global Strategy

    9. Company-wide Strategy (3): Promotion of Our Global Strategy ◆ We will strengthen collaborations in both manufacturing and sales to address the increasing volatility of demand in each country due to geopolitical risks, changes in the trade environment, etc. (1) East Asia ✓ Establishing alliances f

  14. Slide 14: Shift to an Advanced Business Foundation and Sustainability Management

    10. Shift to an Advanced Business Foundation and Sustainability Management Establishing new departments that facilitate improvement from a group-wide perspective to shift to an advanced business foundation Innovation and Technology Head Office Center, HR and Production Solutions Head Office Office A

  15. Slide 15: Overview of Financial Results for the Fiscal Year Ended March 31, 2026

    Section 2 Overview of Financial Results for the Fiscal Year Ended March 31, 2026 14 Copyright© ACHILLES CORPORATION All Rights Reserved.

  16. Slide 16: Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2026

    11. Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 FY 3/2026 targets FY 3/2025 FY 3/2026 (revised on Change February 9) Change Change (%) Percentage Percentage Amount Amount Amount of net sales of net sales (Million yen) Net sales 79,093 100.0% 81,802 100.0% 2,709

  17. Slide 17: Analysis of Factors in Changes in Operating Profit

    12. Analysis of Factors in Changes in Operating Profit +200 2,972 +2,712 Factors increasing operating profit Unit: Million yen Increase in gross profit due to an increase in sales: +400 million yen ✓ Increase in sales of films for the medical sector and films for the electronics sector ✓ Increase in

  18. Slide 18: Overview of the Financial Results of Business Division 1

    13. Overview of the Financial Results of Business Division 1 Net sales Unit: Million yen YoY The increase in net sales was driven by highly 46,293 49,910 +8% functional films and semiconductor-related products. ✓ Sales of films for the medical sector, films for the electronics sector, and products f

  19. Slide 19: Overview of the Financial Results of Business Division 2

    14. Overview of the Financial Results of Business Division 2 Net sales Unit: Million yen YoY Contribution of price revisions in addition to sales +1% increase 22,684 22,964 ✓ The performance of board products in the Heat Insulation Materials BU in the non-housing sector continued to be strong. ✓ The

  20. Slide 20: Overview of the Financial Results of Shoes Business Unit

    15. Overview of the Financial Results of Shoes Business Unit Net sales (12)% Sales decreased mainly due to the deterioration of Unit: Million yen YoY the market environment and the impact of price 10,116 8,928 revisions. ✓ For core brands, we launched new products developed in pursuit of functionali

  21. Slide 21: Statements of Cash Flows

    16. Statements of Cash Flows ◆ Net cash provided by operating (Million yen) FY 3/2025 FY 3/2026 Change activities decreased slightly year on year, to 2.6 billion yen. Trade Net cash provided by (used in) 2,686 2,639 (46) payables decreased due to operating activities responses to the Small and Mediu

  22. Slide 22: Balance Sheet

    17. Balance Sheet ◆ Net assets increased 3.9 billion yen (Million yen) FY 3/2025 FY 3/2026 Change year on year. This was a result of increases of 1.3 billion yen Current assets 45,720 46,645 925 in remeasurements of defined benefit Non-current assets 33,784 36,982 3,198 plans and 1.1 billion yen in

  23. Slide 23: Financial Forecasts for the Fiscal Year Ending March 31, 2027

    Section 3 Financial Forecasts for the Fiscal Year Ending March 31, 2027 22 Copyright© ACHILLES CORPORATION All Rights Reserved.

  24. Slide 24: Summary of Consolidated Financial Forecasts for the Fiscal Year Ending March 31, 2027

    18. Summary of Consolidated Financial Forecasts for the Fiscal Year Ending March 31, 2027 ◆ Net sales are expected to continue to FY 3/2026 2026年 FY 3/2027 2027年 FY 3/2028 2028年 grow, mainly in the medical sector for Change 増減率 (%) (Million yen) results 3月期 実績 targets 3月期 計画 targets 3月期 計画 films and

  25. Slide 25: Capital Investment, Depreciation, and Research and Development Expense Plans

    19. Capital Investment, Depreciation, and Research and Development Expense Plans Capital investment (Million yen) ◆ In the fiscal year ending March 31, 2027, we plan to 5,800 make capital investments of 5.8 billion yen, up 2.3- fold year on year. 2,354 2,464 ◆ We will install manufacturing equipment

  26. Slide 26: Growth Potential of Semiconductor-related Materials

    20. Growth Potential of Semiconductor-related Materials Demand for products for semiconductor transfer (containers, Interleaf, Inner foam, etc.) is growing ✓ Our share of the global market for semiconductor wafer transfer containers, which are used to ship memory semiconductors, is 40% (estimated by

  27. Slide 27: Growth Potential of Films for the Medical Sector

    21. Growth Potential of Films for the Medical Sector Expansion of the business of films for the medical sector Film for the medical sector ✓ Films for the medical sector are used in single-use products. In the fiscal year ended March 31, 2026, orders received from overseas biopharmaceutical companie

  28. Slide 28: Growth Potential of High-performance Heat Insulation Materials

    22. Growth Potential of High-performance Heat Insulation Materials Aiming to tap into the energy-saving demand by providing high-performance heat insulation materials ✓ It is mandatory to conform to energy-saving standards for houses to achieve carbon neutrality by 2050 (see the figure below). Deman

  29. Slide 29: Financial and Capital Strategy

    Section 4 Financial and Capital Strategy 28 Copyright© ACHILLES CORPORATION All Rights Reserved.

  30. Slide 30: Capital Allocation Strategy

    23. Capital Allocation Strategy We optimally allocate cash on hand to growth investments and shareholder returns. In investments, we prioritize human capital investments. Major growth investment topics Operating Human人的資本投資 capital investment Growth 営業CF CF 成長投資 FY 3/2026 FY 3/2027 (plan) investment

  31. Slide 31: Basic Policy on Shareholder Returns

    24. Basic Policy on Shareholder Returns Basic policy on shareholder returns While in principle continuously and stably paying dividends, we will also flexibly purchase treasury shares to comprehensively enhance shareholder returns. ✓ Payment of dividends Dividends are paid in consideration of curren

  32. Slide 32: Disclaimer and Contact for Inquiries

    Disclaimer and Contact for Inquiries These materials were created solely to provide information about Achilles Corporation (hereafter, the "Company"), including management policies, business descriptions, and business performance. They are not intended to solicit investment in the Company. The forwa

  33. Slide 33: Copyright© ACHILLES CORPORATION All Rights Reserved.

    32 Copyright© ACHILLES CORPORATION All Rights Reserved.

Achilles — FY2025 Earnings Presentation on 6ix